Vericel Corp (VCEL)

• Market cap: $2.02B
• 1 day: 0.05%
• 5 days: 0.38%
• 1 month: 15.07%
• 3 months: 11.43%
• 6 months: -5.77%
• Year to date: -27.67%
• 1 year: -24.42%
• 5 years: 55.28%
• 10 years: 2,151.98%
• Sector: Healthcare
• Industry: Biotechnology

About: Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Employees: 357